SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Bernie Goldberg who wrote (1200)4/29/1999 7:21:00 PM
From: Ardner Cheshire, Jr.  Read Replies (1) | Respond to of 1580
 
Bernie, you have me beat. I bought St. Merck @ a split-adjusted 21 1/4 several years ago. This week was my first new purchase since that time.



To: Bernie Goldberg who wrote (1200)4/29/1999 7:35:00 PM
From: muddphudd  Read Replies (1) | Respond to of 1580
 
I think this cycling out of big pharma by institutional investors and fund managers will simply represent a great opportunity to invest in gems like Merck. I, for one, am not too concerned about the patent issues. Merck is a powerhouse. It will continue to invest heavily in R&D, build its pipeline, and bring new products to market. Any dip is a buy op.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News